BIVI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioVie Inc (BIVI) is not a strong buy at the moment given the lack of positive catalysts, weak financial performance, and neutral trading sentiment. The stock does not align well with the user's long-term investment strategy and beginner level, especially considering the company's declining earnings and lack of growth indicators.
The MACD is slightly positive but contracting, RSI is neutral at 52.604, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 1.32 with resistance at 1.419 and support at 1.221.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.
The stock has shown a -7.59% regular market change, weak financial performance with declining EPS (-83.08% YoY) and net income (-15.19% YoY), and no significant trading trends or analyst upgrades.
In Q2 2026, the company reported no revenue growth (0% YoY), a net income decline of -15.19% YoY to -6,069,475, and an EPS drop of -83.08% YoY to -0.77. Gross margin remains at 0%.
No recent analyst ratings or price target changes available.
